Mối liên hệ giữa chiều rộng rìa phẫu thuật và tái phát tại chỗ ở phụ nữ mắc Carcinoma ống dẫn tại chỗ được điều trị bằng liệu pháp bảo tồn vú: Một phân tích tổng hợp

Virnig BA, Tuttle TM, Shamliyan T, Kane RL. Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes. J Natl Cancer Inst. 2010;102:170–8. Wapnir IL, Dignam JJ, Fisher B, et al. Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS. J Natl Cancer Inst. 2011;103:478–88. Irwig L, Bennetts A. Quality of life after breast conservation or mastectomy: a systematic review. Aust N J Surg. 1997;67:750–54. Wang S-Y, Chu H, Shamliyan T, et al. Network meta-analysis of margin threshold for women with ductal carcinoma in situ. J Natl Cancer Inst. 2012;104:507–16. Dunne C, Burke JP, Morrow M, Kell MR. Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ. J Clin Oncol. 2009;27:1615–20. Pilewskie M, Morrow M. Extent and role of margin control for DCIS managed by breast-conserving surgery. In: Newman LA, Bensenhaver JM, editors. Ductal carcinoma in situ and microinvasive/borderline breast cancer. New York: Springer; 2015. pp. 67–83. Moran MS, Schnitt SJ, Giuliano AE, et al. Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. J Clin Oncol. 2014;32:1507–15. American Society of Breast Surgeons. The American Society of Breast Surgeons position statement on breast cancer lumpectomy margins. 2013. https://www.breastsurgeons.org/new_layout/about/statements/PDF_Statements/Lumpectomy_Margins.pdf. Accessed 28 Jul 2016. National Comprehensive Cancer Network (NCCN). NCCN clinical practice guidelines in oncology, breast cancer version 1. 2016. http://www.nccn.org. Accessed 14 Dec 2015. National Institute for Health and Care Excellence (NICE). Early and locally advanced breast cancer: diagnosis and treatment: NICE guidelines [CG80]. 2009. https://www.nice.org.uk/guidance/cg80/chapter/guidance#surgery-to-the-breast. Accessed 14 Dec 2015. New Zealand Guidelines Group (NZGG). Ductal carcinoma in situ. Management of early breast cancer: evidence-based best practice guideline. Wellington: New Zealand Guidelines Group; 2015. pp. 133–41. Senkus E, Kyriakides S, Ohno S, et al. Primary breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015;26:v8–30. Morrow M, Van Zee KJ, Solin LJ, et al. Society of Surgical Oncology—American Society for Radiation Oncology—American Society of Clinical Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in ductal carcinoma in situ. Ann Surg Oncol. 2016. doi:10.1245/s10434-016-5449-z. Vicini FA, Recht A. Age at diagnosis and outcome for women with ductal carcinoma-in situ of the breast: a critical review of the literature. J Clin Oncol. 2002;20:2736–44. Kong I, Narod SA, Taylor C, et al. Age at diagnosis predicts local recurrence in women treated with breast-conserving surgery and postoperative radiation therapy for ductal carcinoma in situ: a population-based outcomes analysis. Curr Oncol. 2014;21:e96–104. Houssami N, Macaskill P, Marinovich ML, Morrow M. The association of surgical margins and local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapy: a meta-analysis. Ann Surg Oncol. 2014;21:717–30. Houssami N, Macaskill P, Marinovich ML, et al. Meta-analysis of the impact of surgical margins on local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapy. Eur J Cancer. 2010;46:3219–32. Vicini F, Beitsch P, Quiet C, et al. Five-year analysis of treatment efficacy and cosmesis by the American Society of Breast Surgeons mammosite breast brachytherapy registry trial in patients treated with accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys. 2011;79:808–17. Hathout L, Hijal T, Theberge V, et al. Hypofractionated radiation therapy for breast ductal carcinoma in situ. Int J Radiat Oncol Biol Phys. 2013;87:1058–63. Ben-David MA, Sturtz DE, Griffith KA, et al. Long-term results of conservative surgery and radiotherapy for ductal carcinoma in situ using lung density correction: The University of Michigan experience. Breast J. 2007;13:392–400. Solin LJ, Fourquet A, Vicini FA, et al. Long-term outcome after breast-conservation treatment with radiation for mammographically detected ductal carcinoma in situ of the breast. Cancer. 2005;103:1137–46. Rodrigues N, Carter D, Dillon D, Parisot N, Choi DH, Haffty BG. Correlation of clinical and pathologic features with outcome in patients with ductal carcinoma in situ of the breast treated with breast-conserving surgery and radiotherapy. Int J Radiat Oncol Biol Phys. 2002;54:1331–5. Cutuli B, Cohen-Solal-Le NC, De LB, et al. Ductal carcinoma in situ of the breast results of conservative and radical treatments in 716 patients. Eur J Cancer. 2001;37:2365–72. Hiramatsu H, Bornstein BA, Recht A, et al. Local recurrence after conservative surgery and radiation therapy for ductal carcinoma in situ: possible importance of family history. Cancer J Sci Am. 1995;1:55–61. Cataliotti L, Distante V, Ciatto S, et al. Intraductal breast cancer: review of 183 consecutive cases. Eur J Cancer. 1992;28:917–20. Turaka A, Freedman GM, Li T, et al. Young age is not associated with increased local recurrence for DCIS treated by breast-conserving surgery and radiation. J Surg Oncol. 2009;100:25–31. Van Zee KJ, Subhedar P, Olcese C, Patil S, Morrow M. Relationship between margin width and recurrence of ductal carcinoma in situ: analysis of 2996 women treated with breast-conserving surgery for 30 years. Ann Surg. 2015;262:623–31. Meattini I, Livi L, Franceschini D, et al. Role of radiotherapy boost in women with ductal carcinoma in situ: a single-center experience in a series of 389 patients. Eur J Surg Oncol. 2013;39:613–8. Chuwa EWL, Tan VHS, Tan P-H, Yong W-S, Ho G-H, Wong C-Y. Treatment for ductal carcinoma in situ in an Asian population: outcome and prognostic factors. ANZ J Surg. 2008;78:42–8. MacAusland SG, Hepel JT, Chong FK, et al. An attempt to independently verify the utility of the Van Nuys prognostic index for ductal carcinoma in situ. Cancer. 2007;110:2648–53. Bijker N, Meijnen P, Peterse JL, et al. Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853. A study by the EORTC breast cancer cooperative group and EORTC radiotherapy group. J Clin Oncol. 2006;24:3381–7. Chasle J, Delozier T, Denoux Y, Marnay J, Michels J-J. Immunohistochemical study of cell cycle regulatory proteins in intraductal breast carcinomas: a preliminary study. Eur J Cancer. 2003;39:1363–9. Nakamura S, Woo C, Silberman H, Streeter J, Lewinsky BS, Silverstein MJ. Breast-conserving therapy for ductal carcinoma in situ: A 20 year experience with excision plus radiation therapy. Am J Surg. 2002;184:403–9. Neuschatz AC, DiPetrillo T, Safaii H, Lowther D, Landa M, Wazer DE. Margin width as a determinant of local control with and without radiation therapy for ductal carcinoma in situ (DCIS) of the breast. Int J Cancer. 2001;96:97–104. Fowble B, Hanlon AL, Fein DA, et al. Results of conservative surgery and radiation for mammographically detected ductal carcinoma in situ (DCIS). Int J Radiat Oncol Biol Phys. 1997;38:949–57. Sweldens C, Peeters S, Van LE, et al. Local relapse after breast-conserving therapy for ductal carcinoma in situ: a European single-center experience and external validation of the memorial Sloan-Kettering Cancer Center DCIS nomogram. Cancer J. 2014;20:1–7. Kim H, Noh JM, Choi DH, et al. Excision alone for small size ductal carcinoma in situ of the breast. Breast. 2014;23:586–90. Lu G, Ades AE. Combination of direct and indirect evidence in mixed treatment comparisons. Stat Med. 2004;23:3105–24. Jansen JP, Trikalinos T, Cappelleri JC, et al. Indirect treatment comparison/network meta-analysis study questionnaire to assess relevance and credibility to inform health care decision making: an ISPOR-AMCP-NPC good practice task force report. Value Health. 2014;17:157–73. Fisher ER, Dignam J, Tan-Chiu E, et al. Pathologic findings from the national surgical adjuvant breast project (NSABP) eight-year update of protocol b-17: intraductal carcinoma. Cancer. 1999;86:429–38. Fish EB, Chapman J-A, Miller NA, et al. Assessment of treatment for patients with primary ductal carcinoma in situ in the breast. Ann Surg Oncol. 1998;5:724–32. Sahoo S, Recant WM, Jaskowiak N, Tong L, Heimann R. Defining negative margins in DCIS patients treated with breast conservation therapy: The University of Chicago experience. Breast J. 2005;11:242–7. Macdonald HR, Silverstein MJ, Mabry H, et al. Local control in ductal carcinoma in situ treated by excision alone: incremental benefit of larger margins. Am J Surg. 2005;190:521–5. Correa C, McGale P, Taylor C, et al. Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. J Natl Cancer Inst Monogr. 2010;162–77. Cutuli B, Cohen-Solal-Le NC, De LB, et al. Breast-conserving therapy for ductal carcinoma in situ of the breast: the French Cancer Centers’ experience. Int J Radiat Oncol Biol Phys. 2002;53:868–79. Tunon-De-Lara C, De-Mascarel I, Mac-Grogan G, et al. Analysis of 676 cases of ductal carcinoma in situ of the breast from 1971 to 1995: diagnosis and treatment. The experience of one institute. Am J Clin Oncol Cancer Clin Trials. 2001;24:531–36. Fisher B, Land S, Mamounas E, Dignam J, Fisher ER, Wolmark N. Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project experience. Semin Oncol. 2001;28:400–18. Chan KC, Fiona KW, Sinha G, et al. Extent of excision margin width required in breast conserving surgery for ductal carcinoma in situ. Cancer. 2001;91:9–16. Warneke J, Grossklaus D, Davis J, et al. Influence of local treatment on the recurrence rate of ductal carcinoma in situ. J Am Coll Surg. 1995;180:683–8. Kestin LL, Goldstein NS, Martinez AA, et al. Mammographically detected ductal carcinoma in situ treated with conservative surgery with or without radiation therapy. Patterns of failure and 10 year results. Ann Surg. 2000;231:235–45. Ringberg A, Idvall I, Ferno M, et al. Ipsilateral local recurrence in relation to therapy and morphological characteristics in patients with ductal carcinoma in situ of the breast. Eur J Surg Oncol. 2000;26:444–51. Rudloff U, Brogi E, Reiner AS, et al. The influence of margin width and volume of disease near margin on benefit of radiation therapy for women with DCIS treated with breast-conserving therapy. Ann Surg. 2010;251:583–91. Gelman A, Rubin DB. Inference from iterative simulation using multiple sequences (with discussion). Stat Sci. 1992;7:457–511. Spiegelhalter DJ, Best NG, Carlin BP, Van Der Linde A. Bayesian measures of model complexity and fit. J R Stat Soc Series B. 2002;64:583–639.